764 related articles for article (PubMed ID: 26332235)
1. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
3. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
4. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
5. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
[TBL] [Abstract][Full Text] [Related]
6. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
Bollela VR; Namburete EI; Feliciano CS; Macheque D; Harrison LH; Caminero JA
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1099-104. PubMed ID: 27393546
[TBL] [Abstract][Full Text] [Related]
7. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Dookie N; Sturm AW; Moodley P
BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
Click ES; Kurbatova EV; Alexander H; Dalton TL; Chen MP; Posey JE; Ershova J; Cegielski JP
J Infect Dis; 2020 Jun; 221(12):2072-2082. PubMed ID: 32002554
[TBL] [Abstract][Full Text] [Related]
10. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
11. A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
Pinhata JMW; Ferrazoli L; Mendes FF; Gonçalves MG; Rabello MCDS; Ghisi KT; Simonsen V; Cavalin RF; Lindoso AABP; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):73-85. PubMed ID: 37943394
[TBL] [Abstract][Full Text] [Related]
12. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
15. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
[TBL] [Abstract][Full Text] [Related]
16. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
Liu Y; Sun Y; Zhang X; Zhang Z; Xing Q; Ren W; Yao C; Yu J; Ding B; Wang S; Li C
Epidemiol Infect; 2021 Jan; 149():e21. PubMed ID: 33397543
[TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of Mycobacterial pharmacogenetics.
Warren RM; Streicher EM; Gey van Pittius NC; Marais BJ; van der Spuy GD; Victor TC; Sirgel F; Donald PR; van Helden PD
Tuberculosis (Edinb); 2009 May; 89(3):199-202. PubMed ID: 19409848
[TBL] [Abstract][Full Text] [Related]
20. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]